# Metabolic Pathway Optimization Agent

**ID:** `biomedical.synthetic_biology.pathway_optimizer`
**Version:** 1.0.0
**Status:** Production
**Category:** Synthetic Biology / Metabolic Engineering

---

## Overview

The **Metabolic Pathway Optimization Agent** uses AI to optimize biosynthetic pathways for producing valuable compounds in microbial cell factories. A 2025 Nature Communications paper demonstrated an autonomous AI-biofoundry platform achieving up to 90-fold improvements in enzyme substrate preference through machine learning-guided optimization.

This agent integrates flux balance analysis, enzyme engineering, and dynamic regulation to maximize production titers while maintaining cell viability—transforming metabolic engineering from trial-and-error to data-driven precision.

---

## Key Capabilities

### 1. Pathway Design

| Task | Method | Output |
|------|--------|--------|
| **Retrosynthesis** | Rule-based + ML | Biosynthetic routes |
| **Enzyme selection** | Sequence mining | Candidate enzymes |
| **Thermodynamic analysis** | eQuilibrator | ΔG predictions |
| **Flux optimization** | FBA/FVA | Optimal flux distribution |

### 2. Enzyme Engineering

- **Substrate optimization:** ML-guided directed evolution
- **Activity enhancement:** Stability and kcat improvement
- **Cofactor switching:** NAD+/NADP+ engineering
- **Expression balancing:** Optimal enzyme ratios

### 3. Dynamic Regulation

| Strategy | Mechanism | Benefit |
|----------|-----------|---------|
| **Biosensors** | Metabolite-responsive TFs | Real-time adjustment |
| **CRISPRi** | Programmable repression | Conditional knockdown |
| **sRNA** | Translational control | Fine-tuning |
| **Protein degradation** | degron tags | Rapid turnover |

### 4. Optimization Algorithms

- **Bayesian optimization:** Sample-efficient parameter search
- **Reinforcement learning:** Sequential decision optimization
- **Genetic algorithms:** Combinatorial design exploration
- **Active learning:** Prioritize informative experiments

---

## Usage

### Example Prompt

```text
Optimize a pathway for lycopene production in E. coli.

Current titer: 50 mg/L
Target: 500+ mg/L

Optimize:
1. Expression levels of pathway enzymes (crtE, crtB, crtI)
2. Precursor supply (IPP/DMAPP from MEP or MVA pathway)
3. Identify bottlenecks and propose solutions
4. Predict optimal fermentation conditions
```

### Expected Output

```
## Lycopene Pathway Optimization

### Current Status
- **Host:** E. coli BL21(DE3)
- **Pathway:** Heterologous carotenoid biosynthesis
- **Current titer:** 50 mg/L
- **Target:** 500 mg/L (10x improvement)

### Pathway Analysis

```
Glucose
    ↓
Glycolysis → G3P + Pyruvate
    ↓ (MEP pathway)
1-Deoxy-D-xylulose 5-phosphate (DXP)
    ↓ dxs ⭐ BOTTLENECK
MEP → IPP ⇌ DMAPP
    ↓ ispA
GPP → FPP → GGPP (crtE)
    ↓ crtB
Phytoene
    ↓ crtI
Lycopene
```

### Bottleneck Identification

| Step | Enzyme | Current Flux | Capacity | Status |
|------|--------|--------------|----------|--------|
| DXS | dxs | 0.42 | 0.45 | **BOTTLENECK** |
| IDI | idi | 0.38 | 0.85 | OK |
| IspA | ispA | 0.35 | 0.72 | OK |
| CrtE | crtE | 0.31 | 0.44 | **BOTTLENECK** |
| CrtB | crtB | 0.28 | 0.82 | OK |
| CrtI | crtI | 0.25 | 0.68 | OK |

### Optimization Strategy

#### 1. Precursor Supply Enhancement

**Recommendation:** Hybrid MEP-MVA pathway

| Modification | Expected Impact |
|--------------|-----------------|
| Overexpress dxs (E. coli) | +40% IPP flux |
| Add MVA pathway (S. cerevisiae) | +80% IPP total |
| Knock out competing pathways (ispH) | +15% flux to GGPP |

#### 2. Enzyme Expression Optimization

**ML-predicted optimal RBS strengths (TIR):**

| Gene | Current TIR | Optimal TIR | Ratio Change |
|------|-------------|-------------|--------------|
| dxs | 5,000 | 25,000 | 5x ↑ |
| idi | 10,000 | 8,000 | 0.8x ↓ |
| ispA | 8,000 | 12,000 | 1.5x ↑ |
| crtE | 5,000 | 20,000 | 4x ↑ |
| crtB | 10,000 | 6,000 | 0.6x ↓ |
| crtI | 8,000 | 15,000 | 1.9x ↑ |

#### 3. Enzyme Engineering

**CrtE (GGPP synthase) - rate-limiting:**

| Mutation | ΔΔG Predicted | Activity Fold |
|----------|---------------|---------------|
| F77L | -1.2 kcal/mol | 2.3x |
| S81T | -0.8 kcal/mol | 1.8x |
| F77L/S81T | -1.9 kcal/mol | 3.4x |

#### 4. Dynamic Regulation

**IPP-responsive biosensor for pathway balancing:**

```
IPP concentration → GadR sensor → Pgad promoter
    → If IPP low: ↑ dxs expression
    → If IPP high: ↑ crtE/crtB/crtI expression
```

### Predicted Titers

| Optimization Level | Predicted Titer | Confidence |
|--------------------|-----------------|------------|
| Baseline | 50 mg/L | - |
| RBS optimization | 180 mg/L | ±30 |
| + MVA pathway | 320 mg/L | ±50 |
| + Enzyme engineering | 480 mg/L | ±70 |
| + Dynamic regulation | 620 mg/L | ±100 |

### Fermentation Optimization

| Parameter | Current | Optimal | Impact |
|-----------|---------|---------|--------|
| Temperature | 37°C | 30°C | +25% stability |
| Induction OD | 0.6 | 0.8 | +15% biomass |
| IPTG | 1 mM | 0.1 mM | Reduced stress |
| Glycerol feeding | None | 5 g/L/h | +40% precursor |
| Duration | 24h | 72h | Fed-batch |

### Implementation Plan

| Phase | Modifications | Expected Titer |
|-------|---------------|----------------|
| 1 | RBS optimization + dxs overexpression | 150 mg/L |
| 2 | Add MVA pathway | 300 mg/L |
| 3 | CrtE F77L/S81T mutant | 450 mg/L |
| 4 | Dynamic IPP sensor | 550+ mg/L |
```

### LLM Agent Integration

```python
@tool
def optimize_metabolic_pathway(
    target_compound: str,
    host_organism: str = "e_coli",
    current_titer: float = None,
    target_titer: float = None,
    optimization_strategy: list[str] = ["expression", "enzyme", "regulation"]
) -> str:
    """
    Optimizes metabolic pathway for compound production.

    Args:
        target_compound: Target compound (KEGG ID or name)
        host_organism: Host organism
        current_titer: Current production titer (mg/L)
        target_titer: Target production titer (mg/L)
        optimization_strategy: List of strategies to apply

    Returns:
        Optimization plan with predicted improvements
    """
    pass
```

---

## Prerequisites

### Required Tools

| Resource | Purpose | Access |
|----------|---------|--------|
| **COBRApy** | Flux balance analysis | Open source |
| **eQuilibrator** | Thermodynamics | API |
| **BRENDA** | Enzyme database | Academic |
| **KEGG** | Pathway database | API |
| **RBS Calculator** | Expression optimization | Salis Lab |

### Dependencies

```
cobra>=0.26
equilibrator-api>=0.4
numpy>=1.24
pandas>=1.5
scikit-learn>=1.3
torch>=2.0
```

---

## References

- **Radivojević et al. (2020):** "A machine learning approach to pathway optimization." *Nature Communications*
- **HamediRad et al. (2019):** "Towards a fully automated algorithm driven platform for biosystems design." *Nature Communications*
- [COBRApy Documentation](https://cobrapy.readthedocs.io/)
- [eQuilibrator](http://equilibrator.weizmann.ac.il/)

---

## Author

**MD BABU MIA**
*Artificial Intelligence Group*
*Icahn School of Medicine at Mount Sinai*
md.babu.mia@mssm.edu
